|
Title |
Description |
Size |
|
A ‘STEP-BY-STEP’ ALGORITHM
FOR THE PROCUREMENT OF CONTROLLED SUBSTANCES FOR DRUG
SUBSTITUTION TREATMENT |
The use of
contaminated injection equipment among injecting drug
users is among the major forces driving the HIV/AIDS
epidemic, contributing about 5-10 per cent of all HIV
transmissions world wide. An essential package to
prevent HIV transmission from injecting drug use
includes needle and syringe programmes, drug
substitution treatment, condom programmes, sexually
transmitted infection control, HIV/AIDS-related
treatment and care, information, education and
communication and peer outreach. |
Pdf 494 kb |
|
A
Rapid Situation Assessment of HIV/STI/TB and Drug Abuse
among Prisoners in Uganda Prisons Service |
The
general prevalence of HIV among prisoners was 11%,
higher among female prisoners at 13% compared to their
male counterparts at 11%. The general prevalence of
syphilis was 5%, lower among female prisoners at 4% than
male prisoners at 5%. |
Pdf 858 kb |
|
ACCESS TO JUSTICE-The Courts |
A
functioning court system is an integral part of a
functioning criminal justice system. The management of
the courts must be efficient and effective so that the
criminal caseload can be adjudicated fairly,
appropriately, and promptly. In many systems, judicial
officers are involved in the day-to-day administration
of courts, yet it is recognized that too heavy an
administrative burden on judicial officers may result in
a loss of efficiency. In some systems, court managers
have been delegated decision-making authority on
operational matters in the courts. A delicate balance
must be struck between alleviating judicial officers of
unnecessary administrative duties on the one hand, and
avoiding the risk of interfering with the independence
of the judiciary on the other. |
Pdf 862 kb |
|
ADVOCACY GUIDE: HIV/AIDS
PREVENTION AMONG INJECTING DRUG USERS |
HIV/AIDS among
IDUs remains a neglected issue. Although policy-makers,
programme planners at the community and national levels
and international donors have paid increasing attention
to HIV/AIDS in recent years, the specific epidemics of
HIV/AIDS among IDUs and the response needed have
attracted much less attention and funding. Efforts have
been made within the United Nations to harmonize
policies on global drug control and HIV/AIDS prevention
and to build interagency collaborative mechanisms;
however, country-level capacity to address HIV/AIDS
among IDUs remains low. Prevention services remain
extremely limited in most places. Care and support
services frequently remain unavailable for IDUs and are
not tailored to their specifi c needs, even where
programming and funding for HIV/AIDS prevention has
considerably expanded otherwise. A review of country
responses in 2002 noted that IDUs tend to be excluded
from highly active antiretroviral therapy, and often
even from basic primary care, almost everywhere. An
extra effort is therefore necessary to promote equal
HIV/AIDS prevention and care among IDUs. |
Pdf 1070 kb |
|
ANTIRETROVIRAL THERAPY AND
INJECTING DRUG USERS |
Despite these
potential benefits, there is a widely held view that
injecting drug users are poor candidates for ARV therapy
because drug dependence undermines drug adherence, or
because medical complications and co-morbidities such as
hepatitis C make co-infected injecting drug users more
difficult to treat and less responsive to ARV therapy.
Although these limitations are indeed problems for many
HIV-positive injecting drug users, extensive experience
and numerous studies have documented that tailored HIV
care for injecting drug users, as for other people
living with HIV, is often highly successful. |
Pdf 1047 kb |
|
Cost-effectiveness of
Australian NSPs |
Sharing of
syringes by injecting drug users (IDUs) is an important
mode of global transmission of blood borne viruses, such
as HIV and hepatitis C virus (HCV). Both HIV and HCV
infection are associated with significant morbidity and
mortality [5, 6]. Needle and syringe programs (NSPs) are
a public health measure designed to reduce the spread of
these infections among IDUs. There are large differences
in HIV epidemics among IDUs between different
international settings. Ecological studies suggest that
where NSPs are not easily accessible, HIV prevalence
tends to be substantially greater than in locations
where NSPs are available. In contrast to HIV infection,
prevalence of HCV among IDUs is generally high in all
locations regardless of the existence of NSPs |
Pdf 237 kb |
|
Criminal Justice Information |
Assessing a criminal justice system can be quite
challenging, particularly when there is very little
quantitative information available on the system itself,
on the problems and the types of crime that it is
confronted with, or on the resources at its disposal.
The capacity and the current performance of the system
itself are difficult to assess in the absence of that
information. Unfortunately, the information that is
available is often of dubious quality. Even when the
required information has been collected and is available
somewhere, it is often still difficult to gather and
analyze the data that could provide an overview of the
crime and security situation and the capacity of the
system itself. Analyzing that data and understanding its
limitations are sometimes beyond the ability of the
assessor who is hard-pressed for time and cannot
necessarily meet with representatives of the main
agencies responsible for collecting that data. |
Pdf 734
kb |
|
Drug Dependence Treatment:
Interventions for Drug Users in Prison |
Interventions and services for drug users in prison are
an essential component of public health care systems as
prisoners are part of our community. Drug treatment
services in prison, also increase staff awareness. The
provision of such services may encourage prison staff to
examine their own use of drugs, alcohol and tobacco as
well as act as peer educators amongst other staff, their
families and the wider community. |
Pdf 4830 kb |
|
EFFECTIVENESS OF STERILE
NEEDLE AND SYRINGE PROGRAMMING IN REDUCING HIV/AIDS
AMONG INJECTING DRUG USERS |
Providing access
to and encouraging utilization of sterile needles and
syringes for IDUs is now generally considered to be a
fundamental component of any comprehensive and effective
HIV-prevention programme. A wide variety of measures
have been developed to improve access to and utilization
of sterile injecting equipment, including needle syringe
programmes (NSP), strategies for disinfecting needles
and syringes where they are reused or shared,
pharmacy-based distribution, sale or exchange schemes,
vending machines and other distribution programmes,
policies and programmes to encourage more appropriate
disposal of used needles and syringes and injecting
paraphernalia legislation. Much effort has been expended
on improving knowledge, changing attitudes and reducing
risk behaviour, but unless the means for behaviour
change also become more readily available, improved
knowledge and attitudes will not result in reduced risk.
Likewise, unless efforts to increase access to sterile
injecting equipment are buttressed by other efforts to
support behaviour change, risk reduction will remain
unaffected. Interventions to improve access to sterile
injecting equipment have been implemented in many
countries throughout the developed world and to a lesser
extent in transitional and developing countries. |
Pdf 343 kb |
|
EFFECTIVENESS OF STERILE
NEEDLE AND SYRINGE PROGRAMMING IN REDUCING HIV/AIDS
AMONG INJECTING DRUG USERS |
After an
outbreak of hepatitis B among IDUs in Amsterdam in 1983,
an organization of IDUs asked municipal health
authorities to provide sterile injection equipment. This
request was initially rejected but the decision was soon
reversed, allowing for the establishment of the first
official needle syringe programme in the world. The
HIV/AIDS pandemic soon became the rationale for this
programme and similar programmes were rapidly
established in many other parts of the world. Needle
syringe programmes now operate officially in over 40
countries. Evaluation of the effectiveness and safety of
these programmes began soon after they were first
established and a vast literature was rapidly generated. |
Pdf 343 kb |
|
Female Drug Use in Pakistan |
This
study is a part of the overall operational research
which includes mapping and size estimation of female
drug users, which forms the first key step in developing
targeted interventions for this highly vulnerable key
population. The results of this mapping study will
assist in understanding the drug using scenario among
female populations, which will ultimately form a
baseline for service provision based on which service
providing organizations will develop targeted
interventions within a specific geographical setting. In
addition to identification of geographical areas where
these populations congregate, this study also provides
valuable information on overall drug use situation in
the targeted communities, economics of drug use,
treatment history, criminal justice history,
availability of treatment services and various religious
and cultural barriers to accessing information and
services among the target group. |
Pdf 4096 kb |
|
GUIDE TO STARTING AND
MANAGING NEEDLE AND SYRINGE PROGRAMMES |
The transmission
of HIV among injecting drug users and related
populations of sex workers, youth and other vulnerable
people is greatly adding to the burden of disease in
countries worldwide. Evidence from 20 years of research
shows that needle and syringe programmes
(NSPs) prevent, control and ultimately reduce prevalence
of HIV and other blood-borne infections among injecting
drug users. These programmes are now operating in more
than 60 countries in all regions of the world; yet it is
estimated that less than 2% of injecting drug users are
able to access sterile needles and syringes through
NSPs. The need for needle and syringe programmes, their
role in a comprehensive response to HIV among injecting
drug users and evidence for their effectiveness can be
found in recent documents |
Pdf 902 kb |
|
HIV and AIDS in places of detention |
This is
for anyone who has anything to do with prisons and
should be read in conjunction with the other modules. It
provides essential background information about HIV and
explains why and how addressing HIV in prisons is linked
to the wider questions of prison reform and to human
rights. |
Pdf 3152 kb |
|
HIV and Prisons in
sub-Saharan Africa |
Prisons
concentrate great numbers of HIV-infected and at-risk
populations, while prisoners comprise one of the least
represented populations in national HIV strategies.
Prison grounds offer ideal conditions for the
transmission of many infectious diseases, including
tuberculosis (and now extensively drug resistant TB or
XDR-TB), hepatitis (A, B and C), sexually transmitted
diseases and HIV6. Overcrowded and unsafe premises where
injecting drug use and unprotected sex are common make
correctional facilities ideal breeding grounds for HIV
infection. The majority of prisoners are male; this is
especially the case in Africa. Given this, the prison
environment is highly conducive to violence and
homosexual sex. Heterosexual and homosexual sex in
prisons—whether voluntary or forced—is a key factor
driving the spread of the infection. Prisoners are not
sealed off; they are often in close contact with the
general population, thus making the prison population a
significant vector of inward and outward transmission of
HIV. |
Pdf 2162 kb |
|
HIV in prisons |
In
2000, Heads of State and Government representatives from
189 countries made an unprecedented commitment in the
United Nations Millennium Declaration4 to halt and
reverse the HIV epidemic by 2015. At the 2005 World
Summit and at the 2006 UN High Level Meeting on AIDS,
world leaders committed “to pursuing all necessary
efforts … towards the goal of universal access to
comprehensive prevention programmes, treatment, care and
support by 2010”. Achieving this objective requires the
inclusion of all sectors in these efforts, including
prisons. |
Pdf 3541 kb |
|
HIV PREVENTION among young
injecting drug users |
The most common
modes of HIV transmission worldwide remain unprotected
sex, unscreened blood and blood products, contaminated
needles, and mother-to-child transmission. In many
countries of Asia, Latin America, Europe and North
America, injecting drug use is the main or a major mode
of HIV transmission. With an estimated 12.5 million
people injecting drugs across the globe, most being
between the ages of 15 and 30, there is a huge potential
for further spread of HIV among drug injectors and their
sexual partners. |
Pdf 1206 kb |
|
HIV testing and counseling in prisons and other closed
settings |
There
is an urgent need to introduce comprehensive HIV
programmes in prisons and to scale them up rapidly. As
part of these programmes, prison systems need to expand
access to HIV testing and counselling, while ensuring
that: (a) prisoners are able to give informed consent to
HIV testing; (b) receive adequate pre-test information
and post-test counselling; and (c) the confidentiality
of test results and of the fact of seeking the test is
guaranteed. |
Pdf 1352 kb |
|
HIV/AIDS prevention and care
for female injecting drug users |
Female injecting
drug users differ from their male counterparts in terms
of their background, their reasons for using drugs, and
their psychosocial needs. However, most HIV/AIDS
prevention and care programmes are not reaching this
vulnerable group because services are designed for men.
Attempts to reach and work with female injecting drug
users are limited and, in fact, gender sensitive
services addressing the specific needs of female
injecting drug users hardly exist in most countries. |
Pdf 95 kb |
|
HIV/AIDS Prevention, Care,
Treatment and Support in Prison Settings |
Worldwide, the levels of HIV infection among prison
populations tend to be much higher than in the
population outside prisons. This situation is often
accompanied and exacerbated by high rates of other
infectious diseases such as hepatitis and tuberculosis.
The generally accepted principle that prisons and
prisoners remain part of the broader community means
that the health threat of HIV within prisons, and the
health threat outside of prisons, are inextricably
linked and therefore demand coordinated action. |
Pdf 562 kb |
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS DRUG DEPENDENCE TREATMENTS-1 |
The
global environment for the HIV response has shifted
substantially towards a massive scaling up of
prevention, treatment, and care interventions. In
particular,
Governments made an unprecedented commitment during the
United Nations Special Session on HIV/AIDS in 2001 to
halting and reversing the epidemic by 2015. More
recently, at the 2005 World Summit and at the 2006 High
Level Meeting on AIDS, Governments committed to pursue
all necessary efforts towards the goal of universal
access to comprehensive prevention programmes,
treatment, care and support by 2010. In support of this,
substantial additional resources to fund an expanded
response have become available, including through the
Global Fund to Fight AIDS, Tuberculosis and Malaria. |
Pdf 871 kb |
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS HIV CARE, TREATMENT AND SUPPORT-2 |
HIV hit
prisons early and hit them hard. The rates of HIV
infection among prisoners in many countries are
significantly higher than those in the general
population. HCV seroprevalence rates are even higher.
While most of the prisoners living with HIV in prison
contract their infection outside the institutions before
imprisonment, the risk of being infected in prison, in
particular through sharing of contaminated injecting
equipment and unprotected sex, is great. Outbreaks of
HIV infection have occurred in a number of prison
systems, demonstrating how rapidly HIV can spread in
prison unless effective action is taken to prevent
transmission. |
Pdf 776 kb |
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS NEEDLE AND SYRINGE PROGRAMMES AND
DECONTAMINATION STRATEGIES-3 |
There
is evidence that needle and syringe programmes (NSPs)
are feasible in a wide range of prison settings,
including in men’s and women’s prisons, prisons of all
security levels, and small and large prisons. There is
evidence that providing clean needles and syringes is
readily accepted by IDUs in prisons and that it
contributes to a significant reduction of syringe
sharing over time. It also appears to be effective in
reducing resulting HIV infections. At the same time,
there is no evidence to suggest that prison-based NSPs
have serious, unintended negative consequences. In
particular, they do not appear to lead to increased drug
use or injecting, nor are they used as weapons.
Evaluations have found that NSPs in prisons actually
facilitate referral of drug users to drug dependence
treatment programmes. Ultimately, since most prisoners
leave prison at some point to return to their community,
implementing NSPs in prisons will benefit not only
prisoners and prison staff, but also society in general. |
Pdf 876 kb |
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS NEEDLE AND SYRINGE PROGRAMMES AND
DECONTAMINATION STRATEGIES-4 |
Illegal
drugs are available in prisons despite the sustained
efforts of prison systems to prevent drug use by
prisoners by undertaking efforts to prevent the entry of
drugs into prisons, by tightly controlling distribution
of prescription medications, and enforcing criminal
prohibitions on illegal drug possession and use among
prisoners. |
Pdf 876 kb |
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS NEEDLE AND SYRINGE PROGRAMMES AND
DECONTAMINATION STRATEGIES-5 |
Coincident with the emergence of HIV, many countries
have experienced a significant increase in the prison
population, resulting in prisons becoming an important
source of health care for socially disadvantaged people,
many of whom cycle in and out of prison. For example, in
1997, 20% to 26% of all HIV positive people in the
United States passed through a correctional facility
(Hammett, Harmon, Rhodes, 2002). Out of the estimated
1600 people living with HIV in Ireland, 300 to 500 had
been through the prison system (UNAIDS, 1997). |
Pdf 776 kb |
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS NEEDLE AND SYRINGE PROGRAMMES AND
DECONTAMINATION STRATEGIES-6 |
Injecting drug use in prison is of particular concern
with regard to transmission of HIV and other blood borne
infections such as hepatitis B and C. This is because
those who inject drugs in prisons often share needles
and syringes and other injecting equipment, which is a very efficient way of
transmitting HIV. |
|
|
INTERVENTIONS TO ADDRESS HIV
IN PRISONS NEEDLE AND SYRINGE PROGRAMMES AND
DECONTAMINATION STRATEGIES-7 |
Some
same-sex sexual activity occurs as a consequence of
sexual orientation (Zachariah et al., 2002). However,
most men who have sex in prisons do not identify
themselves as homosexuals and may not have experienced
same-sex sex prior to their incarceration. Temporarily,
under the conditions of imprisonment, they may engage in
same-sex behaviour (Awofeso & Naoum, 2002, with
reference to Freud, 1905). Many prisoners do not think
of their behaviour as homosexual if they are the
penetrating partner (Johnson, 1971), or are reluctant to
acknowledge any such practice, which often results in
underreporting of sexual activity in prisons (Mahon,
1997). |
Pdf 832 kb |
|
Needle & syringe programs |
Needle and
Syringe Programs have been one of the major public
health success stories. However, some people are still
uncertain about their role. This booklet provides
answers to some of the most frequently asked questions
about Needle and Syringe Programs. |
Pdf 161 kb |
|
POLICY AND PROGRAMMING GUIDE
FOR HIV/AIDS PREVENTION AND CARE AMONG INJECTING DRUG
USERS |
The evidence is
clear: early responses to HIV epidemics among and from
IDUs can prevent their spread. Even where epidemics have
taken off, they can be contained and reversed. |
Pdf 848 kb |
|
POLICY GUIDELINES FOR
COLLABORATIVE TB AND HIV SERVICES FOR INJECTING AND
OTHER DRUG USERS AN INTEGRATED APPROACH |
Drug users tend
to be a marginalized group with complex needs and have
poorer access to life-saving interventions. Services
should have a more coordinated response to drug users’
needs to provide universal access to prevention,
treatment and care services at all entry points. This
requires collaborative planning between HIV and TB
services, specialist drug services and the criminal
justice system. |
Pdf 2306 kb |
|
Prisons and AIDS |
Many of
those who are HIV-positive in prison were already
infected on the outside. Many come from segments of the
population that carry a heavier than average burden of
HIV infections. In addition, many of those in prison are
there because of drug use or trafficking, and they will
try to continue drug use inside. Whether the authorities
admit it or not -- and however much they may try to
repress it -- drugs are introduced and consumed by
prison inmates in many countries, and men commonly have
sex with men in all-male prisons. Denying or ignoring
these facts will not help solve the problem of the
continuing spread of HIV -- and both forms of behaviour
are HIV transmission risks. |
Pfe 248 kb |
|
Protocol on Assessing Drug
Use and HIV in Prison Settings |
The
prison setting population has particular characteristics
that set it apart from the general population. Compared
to the general population, it has a higher prevalence of
psychiatric problems, higher level of suicide and self
harm and higher level of social pressures of different
types (from stress up to, in certain situations, sexual
harassment and sexual and physical abuse). Moreover, the
criminal justice system is an institution with regular
contact with drug dependent users. The inmate population
and given the aforementioned is at higher risk of drug
use whether in terms of initiation of the behavior or
continuation (in the absence of proper intervention).
Post release information suggests that the drug using
population within the prison setting has the
distinctiveness of having of higher risk of drug
overdose on discharge from prison (high post release
mortality). |
Pdf 170 kb |
|
Provision of sterile
injecting equipment to reduce HIV transmission |
The provision of
access to sterile injection equipment for injecting drug
users and the encouragement of its use are essential
components of HIV/AIDS prevention programmes, and should
be seen as a part of overall comprehensive strategies to
reduce the demand for illicit drugs. The equipment is
provided through a great variety of approaches
categorized as needle and syringe programmes, the goals
of which are that drug users have their own sterile
injecting equipment and do not share it with others,
that the circulation time of used needles and syringes
is reduced and that used equipment is disposed of
safely. |
Pdf 143 kb |
|
PROVISION OF STERILE
INJECTING EQUIPMENT TO REDUCE HIV TRANSMISSION |
There is
compelling evidence that increasing the availability and
utilization of sterile injecting equipment for both
out-of-treatment and in-treatment injecting drug users
contributes substantially to reductions in the rate of
HIV transmission. For example, a study published in 2002
compared HIV prevalence in 103 cities in 24 countries.
The HIV infection rate had declined by an average of
18.6% annually in 36 cities with needle and syringe
programmes, whereas it had increased by an average of
8.1% annually in 67 cities lacking such programmes.
These findings confirmed those of earlier reviews. For
example a 1997 study compared HIV infection rates among
injecting drug users in 52 cities without and 29 with
needle and syringe programmes in North and South
America, Europe, Asia and the South Pacific. On average
the HIV infection rate increased by 5.9% per year in the
former and decreased by 5.8% in the cities with needle
and syringe programmes. |
Pdf 206 kb |
|
PROVISION OF STERILE
INJECTING EQUIPMENT TO REDUCE HIV TRANSMISSION |
Communities or
countries threatened by or experiencing an epidemic of
HIV infection among injecting drug users should urgently
adopt measures to increase the availability and
utilization of sterile injecting equipment and to
dispose of used equipment. They should provide
risk-reduction education, referrals to drug-dependence
treatment and abscess management, promote condom use,
HIV testing and counselling, and provide care, treatment
and support for persons with HIV/AIDS and treatment of
sexually transmitted infections. If necessary,
legislation related to drug dependence and drug
paraphernalia should be reviewed and amended in order to
allow for and promote the implementation of needle and
syringe programmes. |
Pdf 206 kb |
|
Reduce prison
overcrowding-Reduce HIV transmission |
Every
year more than 30 million people worldwide enter and
leave prison systems No community remains unaffected |
Pdf 425 kb |
|
Reduction of HIV
transmission in Prisons |
The
rates of HIV infection among inmates of prisons and
other detention centres in many countries are
significantly higher than those in the general
population. Examples include countries in Western and
Eastern Europe, Africa, Latin America and Asia. the
available data on HIV infection rates in prisons cover
inmates who were infected outside the institutions
before imprisonment and persons who were infected inside
the institutions through the sharing of contaminated
injection equipment or through unprotected sex. certain
populations that are highly vulnerable to HIV infection
have a heightened probability of incarceration because
of their involvement in behaviours such as drug use and
sex work. |
Pdf 149 kb |
|
Reduction of HIV
transmission through drug-dependence treatment |
Numerous studies
have yielded consistent and strong evidence that
substitution treatment is associated with substantial
reductions in illicit opioid use, criminal activity,
deaths attributable to overdoses, and risk behaviour
related to HIV transmission. |
Pdf 152 kb |
|
Reduction of HIV
transmission in Prisons |
The evidence obtained in more than 15 years of research
and evaluation involving various types of research
design in different country settings strongly indicates
that outreach-based interventions are effective in
contacting out of-treatment injecting drug users and
providing them with the means for effective behaviour
change. Furthermore, outreach programmes can reinforce
HIV prevention services provided to drug users in
treatment. Specifically, research has consistently
revealed significant and strong post-intervention
effects |
Pdf 166 kb |
|
SEX-RAR Guide: The Rapid
Assessment and Response Guide on Psychoactive Substance
Use and Sexual Risk Behaviour |
This document
provides guidance on using RAR to assess the current
situation regarding substance use and sexual risk
behaviour. An assessment of the local situation, placed
in the country, city or specific community context, is a
necessary requirement for planning and developing
appropriate intervention responses. |
Pdf 646 kb |
|
Southern and Eastern Africa
Declaration of Commitment for HIV and AIDS Prevention
Care, Treatment and Support in Prisons in Africa |
Prisoners are exposed to several HIV transmission risks
whilst in custody: risks associated with unprotected,
forced and consensual sexual practices (especially
“contextual MSM”), injecting drug use (IDU),
tattooing/piercing, sharing of razors, hair clippers,
through to pregnancy and breastfeeding and unsafe
medical or dental care. |
Pdf 392 kb |
|
Substitution maintenance
therapy in the management of opioid dependence and
HIV/AIDS prevention
|
Substitution
maintenance therapy is one of the most effective
treatment options for opioid dependence. It can decrease
the high cost of opioid dependence to individuals, their
families and society at large by reducing heroin use,
associated deaths, HIV risk behaviours and criminal
activity. Substitution maintenance therapy is a critical
component of community-based approaches in the
management of opioid dependence and the prevention of
HIV infection among injecting drug users (IDUs). |
Pdf 488 kb |
|
The global epidemiology of
methamphetamine injection |
This paper
represents an important first step in examining
methamphetamine on a global level. The relationship
between HIV and methamphetamine use is explored within
the context of global diversity. While summarising the
evidence currently available the authors make clear that
much of the picture remains incomplete. Further
investigation is urgently required before we can fully
understand the extent of methamphetamine use in most
countries and the nature and magnitude of related harms. |
Pdf 2035 kb |
|
The Prison System |
Imprisonment can be regarded as the final stage of the
criminal justice process, which starts with the
commission of offences, their investigation, the arrest
of suspects, their detention, trial and sentence. How
the criminal justice system deals with offenders
determines the size of the prison population, which in
turn has a significant impact on the way in which
prisons are managed. The criminal justice system itself
is on the other hand influenced by the government
policies and political climate of the time - determined
to a large extent by the public, which, in democratic
countries, elect their governments. Thus, in assessing
the prison system there needs to be awareness that
efficient management and humane prison conditions are
not dependent on the prison authorities alone. What
happens in prisons is intrinsically linked to how the
criminal justice system as a whole is managed, and what
pressures that system is under from politicians and the
public. Thus, attempts to reform the prison system need
to be undertaken as part of a comprehensive programme
that addresses challenges in the entire criminal justice
system |
pdf 1369 kb |
|
The Rapid Assessment and
Response guide on injecting drug use |
This guide
inevitably draws on the work of a vast number of people
and organizations who have been involved in work on
injecting drug use and HIV infection over the last
decade. It has been heavily influenced by others who
have worked on rapid assessments, not only of drug use
but across a wide range of fields including malaria
control, water sanitation and hygiene control. It has
also been influenced by many methodologists, especially
in sociology, anthropology, epidemiology, and evaluation
research. As such it is a distillation of ‘current
wisdom’ about applied research methods. |
Pdf 816 kb |
|
TRAINING GUIDE FOR HIV
PREVENTION OUTREACH TO INJECTING DRUG USERS |
This package is
designed to help organize workshops that orient and
train public health policy-makers, programme developers,
programme managers, implementers and field workers in
outreach to injecting drug users. The workshops draw on
experience from training materials and tools used in
different parts of the developing and developed world.
The approach advocated in these module aims to
contribute significantly to the prevention of HIV
transmission among injecting drug users. As such, the
workshops you are going to facilitate are an integral
part of a renewed global and national commitment to HIV
prevention. |
Pdf 833 kb |
|
UNAIDS
Guidance Note on HIV and Sex Work |
“…In most
countries, discrimination remains legal against women,
men who have sex with men, sex workers, drug users, and
ethnic minorities. This must change. I call on all
countries to live up to their commitments to enact or
enforce legislation outlawing discrimination against
people living with HIV and members of vulnerable
groups…In countries without laws to protect sex workers,
drug users, and men who have sex with men, only a
fraction of the population has access to prevention.
Conversely, in countries with legal protection and the
protection of human rights for these people, many more
have access to services. As a result, there are fewer
infections, less demand for antiretroviral treatment,
and fewer deaths. Not only is it unethical not to
protect these groups: it makes no sense from a public
health perspective. It hurts us all.” Ban Ki-moon1 The
Secretary-General of the United Nations |
Pdf 227 kb |
|
WHO guidelines on HIV
infection and AIDS in prisons |
All
prisoners have the right to receive health care,
including preventive measures, equivalent to that
available in the community without discrimination, in
particular with respect to their legal status or
nationality. |
Pdf 276 kb |
|
Women and Drug Abuse: The
Problem in India |
Within the
family, it is often the woman, in the role of wife or
mother who is most affected by the individual’s drug
use, and has to bear a significant part of the family
burden. Such impact becomes even more obvious in a
developing country like India, where women are already
disadvantaged. This aspect of the burden of drug use on
women in India has received scant attention. |
Pdf 410 kb |
|
Women and HIV in prison
settings |
Women
prisoners present specific challenges for correctional
authorities despite, or perhaps because of the fact that
they constitute a very small proportion of the prison
population. The profile and background of women in
prison, and the reasons for which they are imprisoned,
are different from those of men in the same situation.4
In particular, injecting drug users and sex workers are
overrepresented. Once in prison, women’s psychological,
social and health care needs will also be different. It
follows that all facets of prison facilities, programmes
and services must be tailored to meet the particular
needs of women offenders. Existing prison facilities,
programmes and services for women inmates have all been
developed initially for men, who have historically
accounted for the largest proportion of the prison
population. |
Pdf 372 kb |
|
Women’s health in prison |
Prison
policies often overlook the special needs of women and
their health. Many women in prison have high levels of
mental illness and drug or alcohol dependence as well as
sexual and physical abuse and violence. Issues arising
from gender-specific health care needs and family
responsibilities are also frequently neglected. Although
women represent a small percentage of the total prison
population, their numbers are increasing and the rate of
increase is much greater than that of men. |
Pdf 407 kb |